| Michael B Mcdonald, MD | |
|
7460 Wolf River Boulevard, Germantown, TN 38138 | |
| (901) 763-0200 | |
| (901) 761-4002 |
| Full Name | Michael B Mcdonald |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 42 Years |
| Location | 7460 Wolf River Boulevard, Germantown, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609876036 | NPI | - | NPPES |
| 00117170 | Medicaid | MS | |
| 4270260 | Other | TN | BCBS |
| 114536001 | Medicaid | AR | |
| 1519965 | Medicaid | TN |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Healthcare Memphis Hospitals | Memphis, TN | Hospital |
| Methodist Healthcare - Olive Branch Hospital | Olive branch, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Specialty Physician Group Llc | 9537291323 | 90 |
| Specialty Physician Group Llc | 9537291323 | 90 |
News Archive
How we perceive the world tells us a lot about how the brain processes sensory information. At this week's meeting of the American Association for the Advancement of Science (AAAS) in Vancouver, McMaster University psychologist Daphne Maurer will report on how vision develops in individuals born with cataracts in both eyes. Although such persons have their vision "corrected" by surgery and contact lenses, Maurer's study shows that they experience specific visual processing deficiencies into adulthood.
A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers.
Some senators on the Finance Committee said Thursday they've moved closer to cutting their health reform bill's cost to under $1 trillion.
Merus Labs International Inc. is pleased to announce that effective at the open of market on Thursday, September 16, 2010, Merus' shares will begin trading on the Canadian National Stock Exchange ("CNSX") under the trading symbol MR. The shares will be quoted on the CNSX in Canadian currency.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has published new research findings on ActA as a potential, anti-cancer component and a new complement to the Company's evolving proprietary Listeria technology platform.
› Verified 4 days ago
| Entity Name | Specialty Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174842181 PECOS PAC ID: 9537291323 Enrollment ID: O20100714000297 |
News Archive
How we perceive the world tells us a lot about how the brain processes sensory information. At this week's meeting of the American Association for the Advancement of Science (AAAS) in Vancouver, McMaster University psychologist Daphne Maurer will report on how vision develops in individuals born with cataracts in both eyes. Although such persons have their vision "corrected" by surgery and contact lenses, Maurer's study shows that they experience specific visual processing deficiencies into adulthood.
A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers.
Some senators on the Finance Committee said Thursday they've moved closer to cutting their health reform bill's cost to under $1 trillion.
Merus Labs International Inc. is pleased to announce that effective at the open of market on Thursday, September 16, 2010, Merus' shares will begin trading on the Canadian National Stock Exchange ("CNSX") under the trading symbol MR. The shares will be quoted on the CNSX in Canadian currency.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has published new research findings on ActA as a potential, anti-cancer component and a new complement to the Company's evolving proprietary Listeria technology platform.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael B Mcdonald, MD 1211 Union Ave Ste 330, Memphis, TN 38104-6655 Ph: () - | Michael B Mcdonald, MD 7460 Wolf River Boulevard, Germantown, TN 38138 Ph: (901) 763-0200 |
News Archive
How we perceive the world tells us a lot about how the brain processes sensory information. At this week's meeting of the American Association for the Advancement of Science (AAAS) in Vancouver, McMaster University psychologist Daphne Maurer will report on how vision develops in individuals born with cataracts in both eyes. Although such persons have their vision "corrected" by surgery and contact lenses, Maurer's study shows that they experience specific visual processing deficiencies into adulthood.
A patient who met many of the published safety guidelines for chloroquine therapy against COVID-19 was observed to have a very abnormal ECG pattern after treatment began, leading to multiple episodes of torsade de pointes (TdP), a life-threatening arrhythmia in which the lower chambers of the heart beat out of sync with the upper chambers.
Some senators on the Finance Committee said Thursday they've moved closer to cutting their health reform bill's cost to under $1 trillion.
Merus Labs International Inc. is pleased to announce that effective at the open of market on Thursday, September 16, 2010, Merus' shares will begin trading on the Canadian National Stock Exchange ("CNSX") under the trading symbol MR. The shares will be quoted on the CNSX in Canadian currency.
Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company, has published new research findings on ActA as a potential, anti-cancer component and a new complement to the Company's evolving proprietary Listeria technology platform.
› Verified 4 days ago
Homayoun Reza Ahmadian, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8060 Wolf River Blvd, Germantown, TN 38138 Phone: 901-271-1000 Fax: 901-271-4187 | |
Mehul B Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7460 Wolf River Blvd, Germantown, TN 38138 Phone: 901-763-0200 Fax: 901-761-4002 | |
Dr. Peter David Snell, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8000 Wolf River Blvd Ste 200, Germantown, TN 38138 Phone: 901-682-1233 Fax: 901-682-0044 | |
William Thomas Rawlinson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7205 Wolf River Blvd, Suite 100, Germantown, TN 38138 Phone: 901-684-1322 Fax: 901-682-6368 | |
Dr. Justin Leonadus Yancey, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7640 Wolf River Cir Fl 2, Germantown, TN 38138 Phone: 901-755-0208 Fax: 901-757-0208 | |
Dr. Michael Aaron Nelson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7751 Wolf River Blvd, Germantown, TN 38138 Phone: 901-297-4000 Fax: 901-531-8344 | |
Kurt W Tauer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7945 Wolf River Blvd, Germantown, TN 38138 Phone: 901-683-0055 Fax: 901-922-6757 |